NCT02438358View on ClinicalTrials.gov

Feasibility Study of Intraoperative Imaging in Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

October 31, 2017

Conditions
Breast Cancer
Interventions
DRUG

LUM015

DEVICE

LUM 2.6 Imaging Device

Trial Locations (1)

Unknown

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

Lumicell, Inc.
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Massachusetts General Hospital

OTHER

collaborator

Dana-Farber Cancer Institute

OTHER

lead

Lumicell, Inc.

INDUSTRY